October 29, 2014

iHealth Lab on Tuesday announced the U.S. launch of the iHealth Edge activity and sleep tracker, which will be available for purchase on Oct. 30.

October 29, 2014

MinuteClinic, the retail medical clinic of CVS Health, opened its first location in Rhode Island on Wednesday inside the CVS/pharmacy store in Woonsocket. Two more walk-in clinics will begin seeing patients Thursday in CVS/pharmacy locations in Cranston and Wakefield.

October 29, 2014

Consumers want to know: do disinfectant products like Reckitt Benckiser's Lysol or Clorox protect against the Ebola virus?

October 28, 2014

The Acetaminophen Awareness Coalition on Tuesday kicked off its annual “Double Check; Don’t Double Up” campaign.

October 28, 2014

Fitbit on Tuesday unveiled three new activity and sleep-tracking products: Fitbit Charge, Fitbit Charge HR and Fitbit Surge. 

October 28, 2014

From Oct. 27 through Nov. 1, 2014, more than 11,000 McKesson employees at more than 170 locations across the United States will participate in the 16th Community Days program.

October 28, 2014

Independent community pharmacies are increasingly providing services to support patient medication adherence and set a new record high in the proportion of prescriptions filled with typically lower-cost generic drugs.

October 28, 2014

Penn Foster on Tuesday announced a new partnership with Walgreens to improve its U.S. Pharmacy Technician Program.

October 28, 2014

The Pharmacy Technician Certification Board on Tuesday announced that Hannah Peabody was selected as the 2014 PTCB Certified Pharmacy Technician of the Year. 

October 28, 2014

The Retail Orphan Initiative on Tuesday hosted a webinar detailing a major charitable campaign to fight Ebola in Liberia.

October 27, 2014

MinuteClinic and Lifespan have entered into a clinical collaboration agreement.

October 27, 2014

Rx Response moved to alert status in response to the concern about Ebola in the United States.

October 24, 2014

GM Pharmaceuticals on Wednesday announced the launch of TexaClear, a new liquid allergy, sinus, cough-cold and flu line, made by Texans for Texans.

October 24, 2014

McKesson Pharmacy Systems and Automation on Thursday announced the launch of its new SecureHIPAA solution.

 

October 23, 2014

Actavis on Thursday confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found United States Patent No. 7,704,984 (the '984 Patent) to be valid.

October 23, 2014

Regional player Bartell Drugs and CareClinic will host “Fall Wellness Day” on Nov. 15 at Bartell Drugs’ Crossroads store in Bellevue, Wash. Bartell pharmacists will provide health services free of charge.

October 23, 2014

The Center for Healthcare Supply Chain Research and the American Association of Colleges of Pharmacy are partnering to provide the nation’s schools of pharmacy a supply chain educational tool surrounding the distribution of specialty pharmaceuticals. 

October 23, 2014

CVS Health and Direct Relief have teamed up to provide $1 million in flu shot vouchers to community health clinic patients in underserved communities who lack health insurance.

October 23, 2014

Preliminary results of an open-label trial carried Thursday in the journal of Headache and Pain reported that a single treatment with ElectroCore’s hand held non-invasive vagus nerve stimulation device GammaCore, completely resolved 44.8% of migraines within 30 minutes.

October 23, 2014

GoGargle! on Wednesday announced the introduction of a new gargle solution to help soothe sore throats.

October 23, 2014

The U.S. healthcare system must address the problem of patients not picking up newly-prescribed medicines, according to a NEHI white paper.

October 22, 2014

The Centers for Disease Control and Prevention highlighted the importance of incorporating pharmacists into team-based care to improve patient health outcomes — a move applauded by the National Association of Chain Drug Stores — during its Public Health Grand Rounds webcast on Tuesday.

October 22, 2014

Pfizer last week announced that the Food and Drug Administration approved a revised label for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release capsules, for oral use, CII, to include abuse-deterrence studies. 

 

October 22, 2014

A JAMA study noted that about two-thirds of dietary supplements recalled by the Food and Drug Administration still contained banned ingredients at least six months after being recalled.